Fermenta Biotech Limited (NSE:FERMENTA)
430.45
-24.55 (-5.40%)
At close: Nov 9, 2026
Fermenta Biotech Market Cap
Fermenta Biotech has a market cap or net worth of 12.36 billion as of November 10, 2026. Its market cap has increased by 50.71% in one year.
Market Cap
12.36B
Enterprise Value
12.79B
Revenue
5.07B
Global Rank
n/a
Country Rank
n/a
PE Ratio
24.88
ChartMarket Cap Chart
Since July 31, 1998, Fermenta Biotech's market cap has increased from 335.80M to 12.36B, an increase of 3,579.90%. That is a compound annual growth rate of 13.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 12.36B | 20.65% |
| Dec 31, 2025 | 10.24B | -4.38% |
| Dec 31, 2024 | 10.71B | 129.56% |
| Dec 29, 2023 | 4.67B | -6.88% |
| Dec 30, 2022 | 5.01B | -40.13% |
| Dec 31, 2021 | 8.37B | -8.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Venus Remedies | 19.54B |
| Syncom Formulations (India) | 18.97B |
| Amrutanjan Health Care | 14.84B |
| TTK Healthcare | 12.90B |
| Fermenta Biotech | 12.82B |
| Bharat Parenterals | 12.78B |
| Kopran | 12.62B |
| Lincoln Pharmaceuticals | 10.17B |